tetanus toxoid
Sponsors
Masonic Cancer Center, University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), Herbert Irving Comprehensive Cancer Center, Gary Archer Ph.D., Jawaharlal Institute of Postgraduate Medical Education & Research
Conditions
Aluminum AllergyCancerColorectal CancerGerm Cell TumorGranulomaHIV InfectionsHepatitis BLeukemia
Phase 1
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
TerminatedNCT00369291
Start: 2003-09-30End: 2010-05-31Updated: 2017-11-29
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
CompletedNCT00639639
Start: 2006-02-06End: 2022-06-01Updated: 2023-03-13
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults
CompletedNCT06302374
Start: 2023-03-04End: 2024-02-19Updated: 2024-03-08
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
Not yet recruitingNCT06939777
Start: 2025-04-30End: 2026-02-28Target: 255Updated: 2025-04-25
Phase 2
Phase 3
Phase 4
Unknown Phase
Vaccination With Tetanus and KLH to Assess Immune Responses.
TerminatedNCT00000105
Start: 2002-07-31End: 2012-03-31Updated: 2017-11-29
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
CompletedNCT00004735
Start: 2000-02-29End: 2006-09-30Updated: 2013-10-07
Characterisation of Human B Cell Maturation in Response to Vaccination
CompletedNCT03535779
Start: 2017-03-06End: 2018-03-13Updated: 2018-06-20
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
CompletedNCT06130462
Start: 2022-09-13End: 2023-02-20Updated: 2023-11-14